Cardiology
News
ACC/AHA issue updated atrial fibrillation guideline
The updated guideline recognizes lifestyle and risk factor modification as a “pillar” of AF management and offers “more prescriptive”...
News
Vagus nerve stimulation promising in POTS
“Collectively, these data suggest that tVNS, a low-cost, low-risk intervention, applied for a short period of time in selected patients with POTS...
News
PTSD symptoms in women tied to worse heart, brain health
Outcomes of interest were associations of PTSD symptoms with carotid intima media thickness, brain white matter hyperintensity volume, and...
News
Bariatric surgery still best option for some with obesity
“Sometimes we might need to go straight to surgery instead of going through medications first, because it may be the most effective and evidence-...
News
At-home blood pressure monitoring is cost effective over long term
Home measurement appeared to be economical over a minimum 10-year period compared with usual care – higher expenditures for equipment and training...
Sponsored Supplement
The Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs: Putting the Evidence in Perspective
News
FDA OKs symplicity renal denervation system for hypertension
The Symplicity Spyral system provides a catheter-based approach to denervate the renal arteries using radiofrequency energy.
News
Single injection reduces blood pressure for 6 months: KARDIA-1
Zilebesiran is a subcutaneous RNA interference therapeutic that binds with high affinity to the hepatic asialoglycoprotein receptor, bringing...
News
PREVENT: AHA’s new risk calculator incorporates CKM health
PREVENT is for use in adults aged 30-79 years and estimates the 10- and 30-year risk of total CVD including, for the first time, heart failure.
Opinion
Revisiting the role of hydrocortisone, fludrocortisone in septic shock
Two decades after choosing not to treat septic shock with hydrocortisone and fludrocortisone, the author describes why he is reconsidering.
Commentary
A better way to control blood pressure
For the American medical-industrial complex, lowered costs for managing common serious diseases may be an undesired rather than a good thing.